Director / PDMR Shareholding & EBT share purchase
Source: RNS
Macfarlane Group PLC
28th March 2024
Macfarlane Group PLC
("Macfarlane" or the "Company)
Director / PDMR Shareholding
and
EBT share purchase
Macfarlane Group PLC (LON: MACF) announces that on 26th March 2024 the following persons discharging managerial responsibilities ('PDMRs') acquired ordinary shares of 25 pence each in the Company ("Shares") for nil consideration upon the maturity of the 26th March 2021 awards under the Company's 2016 Performance Share Plan ("PSP"), together with details of the subsequent sale of certain Shares automatically arranged on their behalf in accordance with the terms of the PSP to satisfy related income tax and national insurance liabilities:
|
PDMR
|
Number of Shares acquired for nil cost (including those added for in respect of dividend equivalent)
|
Number of Shares sold to satisfy income tax and national insurance |
Number of Shares retained post sale |
Total number of Shares held in the Company |
% held of Company's issued share capital |
|
Peter Atkinson
|
375,462 |
169,297 |
206,165 |
1,477,649 |
0.93% |
|
Ivor Gray
|
198,298 |
97,361 |
100,937 |
287,169 |
0.18% |
|
James Macdonald |
54,505 |
26,762 |
27,743 |
30,093 |
0.02% |
In accordance with the terms of the PSP, the number of Shares retained post sale are subject to a two year holding period.
The Company has been informed that today, the Company's employee benefit trust (the "EBT") purchased 293,420 Shares at an average price 133.75 pence per Share to help satisfy any future exercise of share options. As a result, the EBT now holds 330,068 Shares in the Company which is approximately 0.21% of the Company's issued share capital.
The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
1. Peter Atkinson 2. Ivor Gray 3. James Macdonald |
||||
|
2 |
Reason for Notification |
|||||
|
a) |
Position/status |
1. Chief Executive 2. Group Finance Director 3. Company Secretary |
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Macfarlane Group PLC |
||||
|
b) |
LEI |
213800LVRYDERSJAAZ73 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 25 pence each in Macfarlane Group PLC GB0005518872 |
||||
|
b) |
Nature of the transaction |
Settlement of conditional award under the Company PSP acquired for nil consideration. |
||||
|
c) |
Price(s) and volume(s)
|
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable - single transactions Nil |
||||
|
e) |
Date of the transaction |
26 March 2024 |
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
1. Peter Atkinson 2. Ivor Gray 3. James Macdonald |
||||
|
2 |
Reason for Notification |
|||||
|
a) |
Position/status |
1. Chief Executive 2. Group Finance Director 3. Company Secretary |
||||
|
b) |
Initial notification/Amendment |
Initial Announcement |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Macfarlane Group PLC |
||||
|
b) |
LEI |
213800LVRYDERSJAAZ73 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 25 pence each in Macfarlane Group PLC GB0005518872 |
||||
|
b) |
Nature of the transaction |
Disposals arranged by the Company's employee benefit trust to cover income tax and national insurance liabilities |
||||
|
c) |
Price(s) and volume(s)
|
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable - single transactions |
||||
|
e) |
Date of the transaction |
26 March 2024 |
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||
|
Further enquiries: |
Macfarlane Group |
Tel: 0141 333 9666 |
|
|
Aleen Gulvanessian Chair |
|
|
|
Peter Atkinson Chief Executive |
|
|
|
Ivor Gray Finance Director |
|
|
|
|
|
|
|
Spreng Thomson |
|
|
|
Callum Spreng |
Mob: 07803 970103 |
Notes to Editors:
· Macfarlane Group PLC has been listed on the Premium segment of the Main Market of the London Stock Exchange (LSE: MACF) since 1973 with over 70 years' experience in the UK packaging industry.
· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:
o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and
o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.
· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 40 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.
· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.
· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
